Abstract
Leptospirosis causes a wide range of clinical outcomes, including organ failure and death. Early treatment significantly increases the chances of cure. Interleukin-8 (IL-8) is a chemoattractant cytokine for neutrophil and is associated with multiple organ failure. Research has indicated IL-8 to be raised in severe and fatal cases of leptospirosis, but its suitability as a prognostic biomarker has yet to be confirmed. This study aimed to evaluate the significance of IL-8 with the clinical outcomes of leptospirosis patients. Plasma IL-8 was measured in fifty-two samples from hospitalized patients and nineteen healthy controls. The comparisons were made between mild, severe-survived and fatal groups identified by clinical or laboratory findings. IL-8 was significantly higher in fatal (p = 0.01) compared to mild cases. IL-8 was also significantly higher in fatal (p = 0.02) when compared to survived cases of leptospirosis. IL-8 levels in the plasma of fatal leptospirosis cases were significantly elevated compared to survived cases and may serve as a potential prognostic biomarker in determining the possible outcome of leptospirosis patients.
Author supplied keywords
Cite
CITATION STYLE
Wan Yusoff, W. S. Y., Abdullah, M., Sekawi, Z., Amran, F., Yuhana, M. Y., Mohd Taib, N., … Amin Nordin, S. (2020). Elevated levels of IL-8 in fatal leptospirosis. Pathogens and Global Health, 114(2), 99–103. https://doi.org/10.1080/20477724.2020.1724356
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.